{"result": "(\"entity\"<|>HOSPITAL UNIVERSITARIO 12 DE OCTUBRE<|>ORGANIZATION<|>Hospital Universitario 12 de Octubre is a medical institution in Madrid specializing in endocrinology and nutrition, involved in the treatment of hematological patients.)\n##\n(\"entity\"<|>ELENA GARCÍA FERNÁNDEZ<|>PERSON<|>Elena García Fernández is a medical professional associated with the Hospital Universitario 12 de Octubre, focusing on nutrition in hematological patients.)\n##\n(\"entity\"<|>M.ª ÁNGELES VALERO ZANUY<|>PERSON<|>M.ª Ángeles Valero Zanuy is a medical professional at the Hospital Universitario 12 de Octubre, specializing in clinical nutrition.)\n##\n(\"entity\"<|>MIGUEL LEÓN SANZ<|>PERSON<|>Miguel León Sanz is a medical professional at the Hospital Universitario 12 de Octubre, involved in endocrinology and nutrition.)\n##\n(\"entity\"<|>MADRID<|>GEO<|>Madrid is the capital city of Spain, where the Hospital Universitario 12 de Octubre is located.)\n##\n(\"entity\"<|>TRASPLANTE DE CÉLULAS HEMATOLÓGICAS<|>EVENT<|>Hematopoietic cell transplantation is a medical procedure aimed at treating various hematological diseases, requiring specific nutritional support.)\n##\n(\"relationship\"<|>ELENA GARCÍA FERNÁNDEZ<|>HOSPITAL UNIVERSITARIO 12 DE OCTUBRE<|>Elena García Fernández works at the Hospital Universitario 12 de Octubre, focusing on nutrition for hematological patients<|>8)\n##\n(\"relationship\"<|>M.ª ÁNGELES VALERO ZANUY<|>HOSPITAL UNIVERSITARIO 12 DE OCTUBRE<|>M.ª Ángeles Valero Zanuy is a staff member at the Hospital Universitario 12 de Octubre, specializing in clinical nutrition<|>8)\n##\n(\"relationship\"<|>MIGUEL LEÓN SANZ<|>HOSPITAL UNIVERSITARIO 12 DE OCTUBRE<|>Miguel León Sanz is a medical professional at the Hospital Universitario 12 de Octubre, involved in endocrinology and nutrition<|>8)\n##\n(\"relationship\"<|>TRASPLANTE DE CÉLULAS HEMATOLÓGICAS<|>HOSPITAL UNIVERSITARIO 12 DE OCTUBRE<|>The Hospital Universitario 12 de Octubre provides nutritional support for patients undergoing hematopoietic cell transplantation<|>7)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: de evaluación y tratamiento nutricional en el paciente adulto con cáncer. Soporte nutricional en el paciente oncológico 2004; 265-284.\n\n31. Bozzetti F. Home total parenteral nutrition in incurable cancer patients: a therapy, a basic humane care or something in between? Clin Nutr 2003; 22(2):109-11.\n\n32. Schattner M. Enteral nutritional support of the patient with cancer: route and role. J Clin Gastroenterol. 2003 Apr; 36(4):297-302.\n\n33. Huhmann, M. B., & August, D. A. (2008). Review of American Society for Parenteral and Enteral Nutrition (ASPEN) clinical guidelines for nutrition support in cancer patients: nutrition screening and assessment. Nutrition in Clinical Practice, 23(2), 182-188.\n\n34. McCowen KC, Bistrian BR. Immunonutrition: problematic or problem solving? Am J Clin Nutr. 2003 Apr; 77(4):764-70.\n\n35. Gentilini O, Braga M, Gianotti L..Rational base and clinical results of immunonutrition. Minerva Anestesiol. 2000 May; 66(5):362-6.\n\n36. Braga M, Gianotti L, Radaelli G et al. Perioperative Immunonutrition in Patients Undergoing Cancer Surgery. Results of a Randomized Double-blind Phase 3 Trial.Arch Surg. 1999; 134:428-433.\n\n37. Dewey A, Baughan C, Dean T, Higgins B, Johnson I. Eicosapentaenoic acid (EPA, an omega-3 fatty acid from fish oils) for the treatment of cancer cachexia. Cochrane Database Syst Rev. 2007 Jan 24; (1):CD004597.\n\n38. Nanthakumaran S, Brown I, Heys SD, Schofield AC. Inhibition of gastric cancer cell growth by ar-\n---\nTema 40. Valoración y soporte nutricional en el paciente oncológico 653\n\nginine: Molecular mechanisms of action. Clin Nutr. 2008; 28(1):65-70.\n\n39. Wischmeyer PE. Clinical applications of L-glutamine: past, present, and future. Nutr Clin Pract. 2003 Oct; 18(5):377-85.\n\n40. Bozzetti F, Gavazzi C, Mariani L, Crippa F. Glucose based total parenteral nutrition does not stimulate glucose uptake by human tumors. Clin Nutr. 2004; 23:417-421.\n\n41. Tayek JA, Bistrian BR, Hehir DJ, Martin R, Moldawer LL, Blackburn GL. Improved protein kinetics and albumin synthesis by branched chain aminoacid-enriched total parenteral nutrition in cancer cachexia. A prospective randomized crossover trial. Cancer 1986; 58:147-157.\n\n42. Mirhosseini N, Fainsinger RL, Baracos V. Parenteral nutrition in advanced cancer: indications and clini-cal practice guidelines. J Palliat Med. 2005 Oct; 8(5):914-8.\n\n43. Gustafsson UO, Scott MJ, Schwenk W, Demartines N, Roulin D, Francis N, et al., Enhanced Recovery After Surgery Society. Guidelines for perioperative care in elective colonic surgery: enhanced recovery after surgery (ERAS®) society recommendations. Clin Nutr 2012; 31:783-800.\n\n44. Ravasco P, Monteiro-Grillo I, Vidal PM, Camilo ME. Dietary counseling improves patient outcomes: a prospective, randomized, controlled trial in colorectal cancer patients undergoing radiotherapy. J Clin Oncol 2005; 23: 1431-1438.\n\n45. Delia P, Sansotta G, Donato V, Frosina P, Messina G, De Renzis C, et al. Use of probiotics for prevention of radiation-induced diarrhea. World J Gastroenterol 2007; 13:912-915.\n---\nThe image appears to be a blank white page. There is no visible content, text, diagrams, or any other information present in this image. Therefore, I cannot provide any markdown translation or description of content, as there is nothing to transcribe or describe.\n---\n# Tema 41.\n## Soporte nutricional en el paciente hematológico (trasplante de médula ósea y enfermedad de injerto contra huésped)\n\nElena García Fernández\nM.ª Ángeles Valero Zanuy\nMiguel León Sanz\nSección de Endocrinología y Nutrición. Hospital Universitario 12 de Octubre. Madrid\n\nDietoterapia, nutrición clínica y metabolismo. Tercera edición. Copyright 2017 de los autores, SEEN y Grupo Aula Médica.\nTodos los derechos reservados. Páginas 655-674.\n\n1. Introducción\n2. Aspectos generales del trasplante de células hematológicas\n3. Objetivos nutricionales\n4. Valoracion nutricional\n5. Complicaciones que requieren de intervención nutricional\n6. Requerimientos nutricionales en el trasplante hematopoyético\n7. Dietética\n8. Soporte nutricional artificial\n9. Resumen\n10. Bibliografía\n\n### 1. Introducción\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}